An Introduction to Geriatric Oncology
Adults aged 65 years or more account for approximately half of all cancer cases. Geriatric care brings with it additional challenges for oncologists, such as treatment tolerance and managing comorbidities which can play a large role in the availability of treatment options.
Expert video highlights, insights from the conference hub and comprehensive peer-reviewed articles from our journal portfolio provide updates on the changing treatment landscape.
Our supporting partners do not constitute an endorsement of the content on this page.
Geriatric Oncology Content
Nicolaus Kröger, ASH 2018 – Treatment of Myelodysplastic Syndrome in Elderly Patients
Professor Nicolaus Kröger spoke to us at ASH 2018 about the major unmet needs in the treatment of myelodysplastic syndrome in elderly patients, and his phase III study comparing 5-azacytidine induction followed by allogeneic stem cell transplantation versus continuous 5-azacytidine according to donor availability in elderly patients with myelodysplastic syndrome. Questions: 1. What are the […]
Supporting Older People with Cancer – Merging Geriatric and Oncological Knowledge
European Oncology & Haematology, 2016;12(1):23–4 DOI: https://doi.org/10.17925/EOH.2016.12.01.23
It is well known that there is a demographic transition all over the world. The most important explanation to this is the change from previously large groups of children in a family to now commonly only one or two children in most countries. This decrease in birth giving together with improved longevity means that most […]
Breast Cancer Screening in Older Women— Current Evidence and Future Perspectives
Oncology & Hematology Review, 2015;11(1):34–5 DOI: https://doi.org/10.17925/OHR.2015.11.01.34
Breast cancer remains one of the largest contributors to cancer mortality in women in developed countries.1,2 As populations of developed countries are aging, the number of older women who have breast cancer will markedly increase in the upcoming decades. It has been shown that breast cancer prognosis deteriorates with age, even though mortality for other […]
A Systematic Review of Factors Influencing Older Adults’ Hypothetical Treatment Decisions
Oncology & Hematology Review, 2015;11(1):19–33 DOI: https://doi.org/10.17925/OHR.2015.11.01.19
Cancer is a significant health problem in older persons.1 It is estimated that 42 % of all incident cases and over 60 % of mortality due to cancer occur in persons aged 70 and over.1,2 With the aging of the population there will be a considerable increase in the number of older adults diagnosed with […]
How Should We Treat Elderly Newly Diagnosed Multiple Myeloma Patients?
Oncology & Hematology Review, 2015;11(1):43–9 DOI: https://doi.org/10.17925/OHR.2015.11.01.43
Multiple myeloma (MM) is an incurable plasma cell disease that comprises 1 % of all cancers and 10 % of hematologic malignancies. It primarily affects older individuals—the median age at the moment of diagnosis is 70 years—and two-thirds of multiple myeloma patients are over 65 years of age when they are first diagnosed. The outcome […]
Role of the Comprehensive Geriatric Assessment in an Elderly Consultation
Oncology & Hematology Review (US), 2013;9(2):138–141 DOI: https://doi.org/10.17925/OHR.2013.09.2.138
An increasing proportion of elderly people attend medical oncology consultations in which many questions about appropriate treatment will be raised by the oncologist. The balance between treatment benefits (in terms of further life expectancy of the elderly) and risks (hematologic and nonhematologic toxicity, functional impairment, and even death) will be discussed. In many cases, the […]
Management Strategies for Elderly Patients with Diffuse Large B-Cell Lymphoma
European Oncology & Haematology, 2012;8(2):123–6 DOI: https://doi.org/10.17925/EOH.2012.08.02.123
Diffuse large B-cell lymphoma (DLBCL) is the most commonly occurring form of non-Hodgkin lymphoma (NHL), accounting for approximately one-third of adult lymphomas. There was an unprecedented rise in NHL incidence (3–4 % per year) from the 1970s to the mid-1990s, comparable only to the rise in skin cancers.1 It is estimated that there will be […]
Ability of the Comprehensive Geriatric Assessment to Predict Frailty in Older People Diagnosed with Cancer in a General Hospital
European Oncology & Haematology, 2012;8(2):85–8 DOI: https://doi.org/10.17925/EOH.2012.08.02.85
Understanding frailty has become the focus of numerous investigations but, for the moment, there is no universally accepted definition. The concept of frailty has been developing over the past two decades. From the first article that referred to this term, published in 1953,1 to the first article that referred to ‘frailty in the elderly’, published […]
Health Status Screening in Elderly Patients – Is this the Way Forward?
European Oncology & Haematology, 2012;8(1):63–8 DOI: https://doi.org/10.17925/EOH.2012.08.01.63
Europe is undergoing considerable demographic change. It is estimated that people aged over 65 years will make up 28 % of Europe’s population in 2050.1 Many neoplasms develop and are diagnosed in seniors; for example, 65 % of males with prostate cancer are aged over 65 years while women aged 75–79 years have the highest […]
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!